Enzolytics, Inc. is a biotechnology company, which engages in the development and commercialization of drugs for infectious disease treatments. The company’s all-human monoclonal antibodies target and neutralize human immunodeficiency virus and are being employed to produce anti-SARS-CoV-2 monoclonal antibodies for treating COVID-19. Its proprietary therapeutic is also being tested against Hepatitis A, B and C, Rheumatoid Arthritis, certain forms of cancer, rabies, influenza A and B, tetanus, and diphtheria. The company was founded on July 28, 2004 and is headquartered in Allen, TX.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Enzolytics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Enzolytics Inc market cap is $2.56M.
What is the 52-week high for Enzolytics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Enzolytics Inc 52 week high is $0.0024 as of September 05, 2025.
What is the 52-week low for Enzolytics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Enzolytics Inc 52 week low is $0.00 as of September 05, 2025.
What is Enzolytics Inc stock price today?
Enzolytics Inc stock price today is $0.0006.
What was Enzolytics Inc stock price yesterday?
Enzolytics Inc stock price yesterday was $0.0006.
What is the PE ratio of Enzolytics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Enzolytics Inc’s P/E ratio is -6.5.
What is the Price-to-Book ratio of Enzolytics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Enzolytics Inc P/B ratio is -0.0265.
What is the 50-day moving average of Enzolytics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Enzolytics Inc 50-day moving average is $0.0007.
